ropivacaine has been researched along with Carcinoma, Hepatocellular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Lian, Y; Pan, Y; Xie, K; Zhang, R; Zhu, Y | 1 |
| Angenard, G; Beloeil, H; Clément, B; Coulouarn, C; Laviolle, B; Le Gac, G | 1 |
| Jia, WD; Li, YQ; Lv, JG; Qiao, XF; Zhou, H | 1 |
| Chen, Y; Dong, X; Li, M; Li, W; Lin, B; Wang, W; Xu, Z; Zhu, M | 1 |
1 trial(s) available for ropivacaine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effectiveness of Parecoxib Sodium Combined with Transversus Abdominis Plane Block for Pain Management After Hepatectomy for Hepatocellular Carcinoma: A Prospective Controlled Study.
Topics: Abdominal Muscles; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Carcinoma, Hepatocellular; China; Female; Hepatectomy; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Nerve Block; Pain Management; Pain Measurement; Pain, Postoperative; Postoperative Complications; Prospective Studies; Ropivacaine | 2019 |
3 other study(ies) available for ropivacaine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Ropivacaine; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2021 |
Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells.
Topics: Amides; Anesthetics, Local; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lidocaine; Liver Neoplasms; RNA, Messenger; Ropivacaine; Time Factors | 2017 |
Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity.
Topics: Anesthetics, Local; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Liver Neoplasms; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Ropivacaine; Signal Transduction | 2019 |